Neda Lotfi Yagin

Neda Lotfi Yagin

Auto-generated profile, based on publicly available information

Neda Lotfi Yagin

Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
PIPardis Irandoost
Pardis Irandoost
NYNeda Lotfi Yagin
Neda Lotfi Yagin
NNNazli Namazi
Nazli Namazi
AKAbbas Keshtkar
Abbas Keshtkar
FFFarnaz Farsi
Farnaz Farsi
MVMohammadreza Vafa
Mohammadreza Vafa

1 June 2019 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
VAVahideh Ebrahimzadeh Attari
Vahideh Ebrahimzadeh Attari
MSMohammad Hosein Somi
Mohammad Hosein Somi
MAMohammad Asghari Asghari-Jafarabadi
Mohammad Asghari Asghari-Jafarabadi
AOAlireza Ostadrahimi
Alireza Ostadrahimi
SMSeyed-Yaghob Moaddab
Seyed-Yaghob Moaddab
NLNeda Lotfi
Neda Lotfi
Purpose: The present study aimed to assess the effect of ginger (Zingiber officinale) powder supplementation on Helicobacter pylori eradication and improvement of dyspeptic symptoms in patients with H. pylori positive functional dyspepsia (FD). Methods: During this pilot study 15 patients with H. pylori positive FD received 3 g/d ginger powder as three 1-g tablets for 4-weeks. Dyspepsia symptoms were asked before and after the intervention using a questionnaire based on the Rome III criteria. H. pylori eradication was also assessed by a non-invasive stool antigen (HpSAg) test. Results: Ginger consumption accompanied by significant H. pylori eradication rate of 53.3% (P = 0.019) and the odds ratio (95% CI) was 8 (1.07 to 357.14). Moreover, our results showed significant changes in most of the dyspepsia symptoms after ginger supplementation. Conclusion: According to our findings, Z. officinale can be considered as a useful complementary therapy for FD. However, due to the small number of clinical trials in this area, further welldesigned clinical trials are needed to explicitly talk about its effectiveness especially about the eradication of H. pylori.

19 May 2021 in Health Promotion Perspectives
Verified
Journal Article
Open access
PDF file
VEVahideh Ebrahimzadeh-Attari
Vahideh Ebrahimzadeh-Attari
GPGhodratollah Panahi
Ghodratollah Panahi
JHJames Hebert
James Hebert
AOAlireza Ostadrahimi
Alireza Ostadrahimi
MAMaryam Saghafi- Asl
Maryam Saghafi- Asl
BBBehzad Baradaran
Behzad Baradaran
Background: The novel coronavirus (COVID-19) is considered as the most life-threatening pandemic disease during the last decade. The individual nutritional status, though usually ignored in the management of COVID-19, plays a critical role in the immune function and pathogenesis of infection. Accordingly, the present review article aimed to report the effects of nutrients and nutraceuticals on respiratory viral infections including COVID-19, with a focus on their mechanisms of action. Methods: Studies were identified via systematic searches of the databases including PubMed/ MEDLINE, ScienceDirect, Scopus, and Google Scholar from 2000 until April 2020, using keywords. All relevant clinical and experimental studies published in English were included. Results: Protein-energy malnutrition (PEM) is common in severe respiratory infections and should be considered in the management of COVID-19 patients. On the other hand, obesity can be accompanied by decreasing the host immunity. Therefore, increasing physical activity at home and a slight caloric restriction with adequate intake of micronutrients and nutraceuticals are simple aids to boost host immunity and decrease the clinical manifestations of COVID-19. Conclusion: The most important nutrients which can be considered for COVID-19 management are vitamin D, vitamin C, vitamin A, folate, zinc, and probiotics. Their adequacy should be provided through dietary intake or appropriate supplementation. Moreover, adequate intake of some other dietary agents including vitamin E, magnesium, selenium, alpha linolenic acid and phytochemicals are required to maintain the host immunity.

23 December 2012 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
RMReza Mahdavi
Reza Mahdavi
NYNeda Lotfi Yagin
Neda Lotfi Yagin
MLMichael Liebman
Michael Liebman
ZNZeinab Nikniaz
Zeinab Nikniaz

3 November 2022 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
HBHadi Bazyar
Hadi Bazyar
KNkhadijeh Nasiri
khadijeh Nasiri
PGParisa Ghanbari
Parisa Ghanbari
EMElahe Mohammadi
Elahe Mohammadi
NYNeda Lotfi Yagin
Neda Lotfi Yagin
SAShafagh Ali Asgarzadeh
Shafagh Ali Asgarzadeh
Background: The role of the Endocannabinoids (ECs) in insulin resistance, and their association with visceral obesity and metabolic profile have been studied extensively. Since the association between ECs and metabolic factors in Gestational Diabetes Mellitus (GDM) are not clear, we aimed to evaluate the levels of N-Arachidonoylethanolamide (AEA) and 2-Arachidonoylglycerol (2-AG) and their association with C-reactive protein (CRP), glycemic indices, blood pressure, and anthropometric indices in pregnant women with GDM. Methods: The present case–control study was conducted among 96 singleton pregnant women aged 18–40 years, including 48 healthy pregnant women (control group) and 48 women with a positive diagnosis of GDM (case group). Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for GDM were checked according to endocannabinoids and anthropometric indices using Multivariable Logistic Regression. Results: AEA was significantly associated with increased risk of GDM in models 1, 2 and 3 (OR = 1.22, 95% CI: 1.06–1.41; OR = 1.54, 95% CI: 1.19–1.97; OR = 1.46, 95% CI:1.11–1.91). A positive but no significant association was found for AEA in model 4 (OR = 1.38,95% CI: 0.99–1.92). Similar to AEA, 2-AG was also positively associated with the likelihood of GDM in Models 1, 2, and 3 but the association attenuated to null in model 4 (OR = 1.25; 95% CI: 0.94- 1.65). Conclusions: Our findings showed that levels of ECs were significantly higher in pregnant women with GDM compared to healthy ones. Also, ECs levels were associated with the likelihood of GDM, independent of BMI and weight gain.

4 December 2024 in Journal of Research in Clinical Medicine
Verified
Journal Article
Open access
PDF file
MLMahshid Naser Langroodi
Mahshid Naser Langroodi
AAAkbar Aliasgharzadeh
Akbar Aliasgharzadeh
MNMostafa Najafipour
Mostafa Najafipour
NYNeda Lotfi Yagin
Neda Lotfi Yagin
FNFarzad Najafipour
Farzad Najafipour
Introduction: Acromegaly, characterized by overproduction of growth hormone (GH) and insulin-like growth factor 1 (IGF1), increases the risk of mortality and morbidities. Monitoring is a crucial aspect of managing and treating of acromegaly patients. In various studies, patients with active acromegaly have shown discordance between GH and IGF-1 results after surgery. In this study, the discrepancy between these two tests in monitoring acromegaly patients was evaluated. Methods: The levels of IGF-1 and GH after OGTT in 49 acromegalic patients who underwent surgery at least 3 months earlier and had been referred to clinic for follow-up were analyzed. Clinical and metabolic parameters, GH nadir, and IGF-1 values were compared between groups. Results: Fifty-one percent of patients had normal IGF-1 based on their age and sex, and 57.1% of patients had GHn<1 µg/L. Based on IGF-1 and GHn results, 23 patients had discordant results. The most common pattern of discordance was high IGF-1 and normal GH nadir that was seen in 13 patients. A pattern of high GH and normal IGF-1 was seen in 10 patients. There was a significant difference between the corrected IGF-1 values of the high IGF-1 group and those of active disease group (P=0.001). There was no significant difference in GHn between high GHn group and active disease group (P=0.8). Conclusion: There is a significant inconsistency between the results of IGF-1 and GHn in monitoring of acromegaly patients. Also, when GH-0 is<1 µg/L the use of GHn does not help and there is a need for more frequent monitoring for early diagnosis of the disease recurrence.